The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

MLA

J, Cortes, et al. “The Value of High-Dose Systemic Chemotherapy and Intrathecal Therapy for Central Nervous System Prophylaxis in Different Risk Groups of Adult Acute Lymphoblastic Leukemia.” Blood, vol. 86, no. 6, Sept. 1995. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7bbb2855b97bf595b7e67600c5e96bfd&authtype=sso&custid=ns315887.

APA

J, C., S M, O., S, P., M J, K., E J, F., & H M, K. (1995). The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood, 86(6).

Chicago

J, Cortes, O’Brien S M, Pierce S, Keating M J, Freireich E J, and Kantarjian H M. 1995. “The Value of High-Dose Systemic Chemotherapy and Intrathecal Therapy for Central Nervous System Prophylaxis in Different Risk Groups of Adult Acute Lymphoblastic Leukemia.” Blood 86 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7bbb2855b97bf595b7e67600c5e96bfd&authtype=sso&custid=ns315887.